Politixia
Argentina President Javier Milei and U.S. Health and Human Services Secretary Robert F. Kennedy, Jr.
In a new response to Warren, RFK Jr. claims TrumpRx does not store prescription information — raising questions about whether Administration savings claims were “made up out of thin air.”
“Your ongoing refusal to release these deals raises questions about whether the Trump administration is trying to hide the fact that it is giving billion-dollar handouts to Big Pharma without getting anything meaningful in return for Americans.”
Text of Letter (PDF) | RFK Jr. Response (PDF)
August 14, 2026 – Washington, D.C. — U.S. Senator Elizabeth Warren (D-Mass.) has slammed Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for his refusal to release the Trump administration’s secret pricing deals with drug companies and for breaking a promise he made to Warren in a recent hearing. Senator Warren also released a new response from Secretary Kennedy that raises doubts about the accuracy of the Trump administration’s claims of cost savings from the secret pharma deals.
The letter comes after Dr. Mehmet Oz, the CMS Administrator, admitted that President Trump’s “Most-Favored-Nation” (MFN) prescription drug pricing deals will expire at the end of the President’s term. The drug manufacturers that entered into these deals will benefit from huge tariff exemptions for branded drugs and vouchers to fast-track approvals for new products – lucrative perks that they received while doing little to reduce drug costs for the American public.
At a recent Senate Finance Committee hearing, Kennedy committed to Warren that he would disclose the administration’s pricing deals with drug companies, stating, “I’m happy to make the deals available.” Senator Warren pressed Kennedy to make good on his promise in a follow-up letter, but Kennedy has failed to do so.
Now, in a new response to Warren, Kennedy once again dodged his promise to release details of the secret drug pricing deals to the American public and instead revealed new information that casts serious doubts on the Trump administration’s claims of savings for Americans.
The same week that Kennedy replied to Warren, the White House claimed that TrumpRx had saved Americans more than $700 million. But in his response, Kennedy admitted that TrumpRx “does not store any patient, health, or prescription information.” Without this information, the accuracy of any claims of savings made by the Trump administration is unreliable.
“On its face, this is an admission of failure,” said the senator. “But your response to me raises questions about whether even that estimate was made up out of thin air.”
The senator also raised concerns about the administration’s efforts to raise drug prices overseas in what would be a boon for drug companies. Reports indicate that the Trump administration is “launching a full-scale charm offensive across Europe to persuade governments…to pay more for medicines” — and using the threat of tariffs to strong-arm countries if that does not work. Drug companies are reportedly “already leveraging the pressure from the U.S. to try to get European countries to pay more” for prescription drugs.
At the same time, drug manufacturers, including the ones participating in these MFN deals, continue to raise drug prices undeterred. In January, prices increased for 872 drugs, and for hundreds more throughout the spring and summer.
“You committed to bringing ‘radical transparency’ to the Department of Health and Human Services (HHS), but your ongoing refusal to release these deals raises questions about whether the Trump administration is trying to hide the fact that it is giving billion-dollar handouts to Big Pharma without getting anything meaningful in return for Americans,” wrote Senator Warren.
“Americans deserve to know whether the deals the administration is cutting with Big Pharma will lower their prescription drug costs — or just further enrich big drug companies,” continued Senator Warren.
Senator Warren asked Kennedy to provide answers to her questions regarding these prescription drug pricing deals no later than August 27, 2026.
Senator Warren has led efforts to push back against Big Pharma and use every tool available in government to lower drug prices:
GIPHY App Key not set. Please check settings